In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NewGen Therapeutics, Inc.

Latest From NewGen Therapeutics, Inc.

Deals Shaping the Medical Industry (2/2012)

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Medical Device BioPharmaceutical

NewGen Therapeutics Inc.

NewGen Therapeutics Inc. aims to exploit weaknesses in the intellectual property protecting certain cancer drugs that already are blockbusters or that appear destined to be highly successful in coming years. The plan is to create functionally improved versions of valuable cancer drugs and develop them as treatments for specific subsets of patients likely to respond well.

BioPharmaceutical

Start-Up Previews

This Month's Profile Group: Breast Cancer Diagnostics: Start-Ups Look To Fill Gaps In The Patient Care Continuum, features profiles of Delphinus Medical Technologies, Ibris, NovaScan and Real Time Tomography. Plus these Start-Ups Across Health Care: NewGen Therapeutics, Ozics, PlantForm and PsiOxus.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register